期刊文献+

磷脂酰肌醇蛋白聚糖-3在原发性肝癌中的表达及临床意义 被引量:5

Expression and clinical significance of glypican-3 in primary hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨磷脂酰肌醇蛋白聚糖-3(glypican-3,GPC3)在原发性肝癌中的表达及临床意义。方法采用免疫组化法检测45例手术切除的原发性肝癌及癌旁组织中GPC3的表达水平,比较原发性肝癌不同临床病理特征中GPC3的表达差异,分析GPC3表达与临床和病理因素的相关性。结果肝癌组织GPC3表达评分[(10.3±2.5)分]显著高于癌旁组织[(3.2±0.8)分],差异有统计学意义(P<0.05);不同性别、年龄组间GPC3蛋白表达比较,差异无统计学意义(P>0.05),而不同临床分期、肿瘤直径及有无转移患者比较,差异有统计学意义,GPC3在临床分期晚、肿瘤直径大、分化程度低及远处有转移的患者肝癌组织中表达强度增高(P<0.05)。logistic回归分析显示,PHC患者肝癌组织中GPC3表达与临床分期、肿瘤直径、分化程度及远处有转移等因素紧切相关(OR=0.623~0.960,P<0.05)。结论 GPC3蛋白在肝癌组织中呈高表达状态,对于其病情的诊断及预后评估具有重要价值。 Objective To study the expression and clinical significance of glypican-3 (GPC3) in primary hepatic earcinoma(PHC). Methods Immunohistochemistry was applied to detect GPC3 expression in 45 cases of PHC. The corre- lation between exprssion levels of GPC3 and clinieopathologic factors was analyzed. Results The exprssion levels of GPC3 in PHC tissues were significantly higher than those in adjacent normal tissues [(10.3~2.5)vs.(3.2+0.8), P 〈 0.05]. There were no significant differences of GPC3 expression levels in different age group , in male and female groups (P 〉 0.05). But there were significant differences in different clinical stage, tumor diameter, tumor cell differentiation and metastasis or not. The expression degree of GPC3 highly increased in late clinical stage, larger tumor size, less differ- entiation and metastasis. The expression levels of GPC3 in hepatocellular carcinoma tissues were closely related to clinical stage, tumor size, differentiation and metastasis (OR = 0.623-0.960, P 〈 0.05). Conclusion GPC3 expresses high in PHC tissues, which could act as a biomarker for evaluating disease condition and prognosis.
出处 《北京医学》 CAS 2013年第6期423-426,I0002,共5页 Beijing Medical Journal
关键词 肝细胞癌 磷脂酰肌醇蛋白聚糖-3 基因表达 Hepatocellular carcinoma Glypican-3 (GPC3) Gene expression
  • 相关文献

参考文献4

二级参考文献46

  • 1Hui Liu, Li-Jie Zhang,Peng Li, Yun Zhai, Yu-Fen Tan, Ning Li, Hui-Guo Ding,Chun-Feng Qu.Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(35):4410-4415. 被引量:57
  • 2Yao, Deng-Fu,Dong, Zhi-Zhen,Yao, Min.Specific molecular markers in hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2007,6(3):241-247. 被引量:55
  • 3韦立新,石怀银.肝癌前病变与高分化肝癌的病理诊断与鉴别[J].中华病理学杂志,2006,35(2):117-118. 被引量:14
  • 4Louis L,Tamara S,David C,潘敏鸿(摘译),饶秋(摘译),周晓军(审校).GPC3在鉴别小肝癌与肝硬化、异型增生结节和局灶性结节性增生中的作用[J].临床与实验病理学杂志,2006,22(6):653-653. 被引量:44
  • 5EI - Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis [ J ]. Gastroenterology, 2007,132 : 2557 - 2576.
  • 6叶任高.内科学[M].第2版.北京:北京人民卫生出版社,2002:471-479.
  • 7Capurro MI, Xiang YY, lobe, et al. Glypican -3 promotes the growth of hepatoceBuar carcinoma by stimulating canonical Wnt signaling[J]. Cancer Res, 2005, 65( 14): 6245-6254.
  • 8Capurro MI, Xiar.g YY, lobe C, et al. Glypican -3 promotes the growth of hepatocelular carcinoma by stimulating canonical Wnt signaling[ J ]. Cancer Res, 2005,65:6245 - 6254.
  • 9Nakalsura T, Yoshitake Y, Senju S, et al. Glypiean - 3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker [ J ]. Biochem Biophys Res Commun,2003,306 : 16 - 25.
  • 10Gupta S, Bent S, Kohlwes J. Test characteristics of alphafetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C [ J]. A systematic review and critical analysis. Ann Intern Med,2003,139:46 - 50.

共引文献65

同被引文献43

  • 1Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China (Yao M,Yao DF,Qiu LW,Wu W,Sai WL,Yang JL and Zhang HJ),Department of Oncology,Yancheng First People’s Hospital,Yancheng 224001,China (Bian YZ),Department of Oncology,Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China (Zhang CG).Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量:51
  • 2Jain S,Singhal S,Lee P,Xu R.Molecular genetics of hepatocellular neoplasia.Am J Transl Res,2010,2(1):105-118.
  • 3Ozkan H,Erdal H,Kogak E,Tutkak H,Karaeren Z,Yakut M,Koklii S.Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma.J Clin Lab Anal, 2011,25(5):350-353.
  • 4Yan B,Wei JJ,Qian YM,Zhao XL,Zhang WW,Xu AM,Zhang SH.Expression and clinicopathologic significance of glypican 3 in hepatocellular carcinoma.Ann Diagn Pathol,2011,15(3):162-169.
  • 5Abdul-Al HM,Makhlouf HR,Wang G,Goodman ZD.Glypican-3 expression in benign liver tissue with active hepatitis C:implicationsfor the diagnosis of hepatocellular carcinoma. Hum Pathol,2008,39(2):209-212.
  • 6Leistner CM,Gruen-Bernhard S,Glebe D.Role of glycosaminoglycans for binding and infection of hepatitis B vims.Cell Microbiol,2008,10(1):122-133.
  • 7Andreo U,Maillard P,Kalinina 0,Walic M,Meurs E,Martinot M,Marcellin P,Budkowska A.Lipoprotein lipase mediates hepatitis C vims (HCV) cell entry and inhibits HCV infection.Cell Microbiol,2007,9(10):2445-2456.
  • 8康凯夫,张鑫,陈小伍,陈坚平,罗小丽.Glypican-3在原发性肝细胞性肝癌中的表达及其临床意义[J].广东医学,2009,30(10):1480-1482. 被引量:2
  • 9程华,闫静辉.Glypican-3与肿瘤关系的研究进展[J].生物技术通报,2010,26(2):33-37. 被引量:4
  • 10王书奎.胰岛素样生长因子2的基因组印迹及与肿瘤关系的研究进展[J].医学研究生学报,2010,23(2):113-116. 被引量:12

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部